Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: Novel and selective histamine H3 receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 7, 2003, Pages 1325-1328

  Faghih, Ramin ^a   Dwight, Wesley ^a,b   Pan, Jia Bao ^a   Fox, Gerard B ^a   Krueger, Kathy M ^a   Esbenshade, Timothy A ^a   McVey, Jill M ^a   Marsh, Kennan ^a   Bennani, Youssef L ^a,c   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

^c ATHERSYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 349821; AMIDE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 0037424719     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00118-5     Document Type: Article

References (26)

1. (a) Leurs R., Watanabe T., Timmerman H. Trends Pharmacol. Sci. 22:2001;337
2. (b) Hough L.B. Mol. Pharmacol. 59:2001;415.
3. (a) Arrang J.-M., Garbarg M., Schwartz J.-C. Nature (London). 302:1983;832
4. (b) Arrang J.-M., Garbarg M., Lancelot J.-C., Lecomte J.-M., Pollard H., Robba M., Schunack W., Schwartz J.-C. Nature (London). 327:1987;117
5. 3Receptor A Target for New Drugs; Leurs, R., Timmerman, H., Eds. Pharmacochemistry Library Volume 30; Elsevier: Amsterdam, 1998.
6. (d) Leurs R., Blandina P., Tedford C., Timmerman H. Trends Pharmacol. Sci. 19:1998;177
7. (e) Lovenberg T.W., Pyati J., Chang H., Wilson S.J., Erlander M.G. J. Pharmacol. Exp. Ther. 293:2000;771
8. (f) Leurs R., Hoffmann M., Wieland K., Timmerman H. Trends Pharmacol. Sci. 21:2000;11.
9. (a) Bush, E. N.; Shapiro, R.; Nuss, M.; Knourek-Segel, V.; Wilcox, D.; Droz, B.; Faghih, R.; Bennani, Y.; Esbenshade, T.; Jacobson, P. B.; Hancock, A. A. Abstracts, American Diabetes Association, 2002 1715-P.
10. (b) Krueger K.M., Kang C.-H., Miller T., Witte D., Faghih R., Bennani Y.L., Esbenshade T.A., Hancock A. Pharmacologist. 44(Suppl 1):2002;A196
11. (c) Hancock A., Fox G., Bush E., Shapiro R., Nuss M., Knourek-Segel V., Wilcox D., Droz B., Jacobson P., Bennani Y.L., Esbenshade T., Faghih R. Pharmacologist. 44(Suppl 1):2002;A157
12. (d) Tozer M.J., Kalindjian S. B. Expert Opin. Ther. Pat. 10:2000;1045.
13. (a) Faghih R., Dwight W., Vasudevan A., Dinges J., Conner S.E., Esbenshade T., Bennani Y.L., Hancock A.A. Bioorg. Med. Chem. Lett. 12:2002;3077
14. (b) Faghih R., Dwight W., Black L., Liu H., Gentles R., Phelan K., Esbenshade T.A., Ireland L., Miller T.A., Kang C.-H., Krueger K.M., Fox G.B., Hancock A.A., Bennani Y.L. Bioorg. Med. Chem. Lett. 12:2002;2035
15. (c) Ting P.C., Lee J.F., Albanese M.M., Tom W.C., Solomon D.M., Aslanian R., Shih N.-Y., West R. Bioorg. Med. Chem. Lett. 12:2002;2643
16. (d) Shah C., McAtee L., Breitenbucher G., Rudolph D., Li X., Lovenberg T.W., Mazur C., Wilson S.J., Carruthers N.I. Bioorg. Med. Chem. Lett. 12:2002;3309.
17. Halpern M.T. Curr. Opin. Cent. Peripher. Nerv. Syst. Invest. Drugs. 1:1999;524.
18. Kathmann M., Schlicker E., Marr I., Werthwein S., Stark H., Schunack W. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;623.
19. Lovenberg T.W., Roland B.L., Wilson S.J., Jiang X., Jayashree P., Huvar A., Jackson M.R., Erlander M.G. Mol. Pharmacol. 55:1999;1101.
20. Hancock, A. A.; Esbenshade, T. A. In Current Protocols in Pharmacology Enna, S., Williams, M., Ferkany, J., Kenakin, T., Porsolt, R., Sullivan, J. Eds.; John Wiley & Sons: 2000; Vol. 1.19, p 1.
21. Garbarg M., Arrang J.-M., Rouleau A., Ligneau X., Tuong M.D., Schwartz J.-C., Ganellin C.R. J. Pharmacol. Exp. Ther. 263:1992;304.
22. Fox G.B., Pan J.B., Esbenshade T.A., Bitner R.S., Nikkel A.L., Miller T., Kang C.-H., Bennani Y.L., Black L.A., Faghih R., Hancock A.A., Decker M.W. Pharmacol. Biochem. Behav. 72:2002;741.
23. (a) Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. J. Biol. Chem. 275:2000;36781
24. (b) Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., Rauser L., Lee S.P., Lynch K.R., Roth B.L., O'Dowd B.F. Mol. Pharmacol. 59:2001;427
25. (c) Liu C., Ma X.-J., Jiang X., Wilson S.J., Hofstra C.L., Blevitt J., Pyati J., Li X., Chai W., Carruthers N., Lovenberg T.W. Mol. Pharmacol. 59:2001;420.
26. Apelt J., Ligneau X., Pertz H.H., Arrang J.-M., Ganellin R.C., Schwartz J.-C., Schunack W., Stark H. J. Med. Chem. 45:2002;1128.